Lithuania vs Romania: Expected chances of death from non-communicable diseases, by gender
Lithuania
29.1%
in 2021
Romania
29.0%
in 2021
Lithuania rank
29th
Romania rank
30th
Expected chances of death from non-communicable diseases, by gender over time
- Lithuania
- Romania
How they compare
Lithuania currently reports 29.1% against 29.0% in Romania, a difference of 0.1%.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Lithuania ahead.
Lithuania ranks 29th and Romania ranks 30th of 185 countries.
Lithuania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lithuania | Romania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.5% | 33.6% | 2.9% | Lithuania |
| 2010s | 32.1% | 29.7% | 2.4% | Lithuania |
| 2020s | 29.8% | 29.4% | 0.4% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher expected chances of death from non-communicable diseases, by gender, Lithuania or Romania?
- Lithuania, at 29.1% against 29.0% in Romania as of 2021.
- What is the difference in expected chances of death from non-communicable diseases, by gender between Lithuania and Romania?
- 0.1%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Romania?
- 22 years are reported by both, from 2000 to 2021.
- How do Lithuania and Romania rank globally for expected chances of death from non-communicable diseases, by gender?
- Lithuania ranks 29th and Romania ranks 30th of 185 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Expected chances of death from non-communicable diseases, by gender. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated share of 30-year-olds who would die before their 70th birthday from common non-communicable diseases: any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease.